Dr Martens PLC
LSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
Braskem SA
NYSE:BAK
|
BR |
|
E
|
Electro Optic Systems Holdings Ltd
OTC:EOPSF
|
AU |
|
Emerging Towns & Cities Singapore Ltd
SGX:1C0
|
SG |
|
Prada SpA
F:PRP0
|
IT |
|
N
|
Navigator Company SA
ELI:NVG
|
PT |
|
GLG Corp Ltd
ASX:GLE
|
SG |
|
S
|
Sporton International Inc
TPEX:6146
|
TW |
|
T
|
TenX Protocols Inc
XTSX:TNX
|
CA |
|
S
|
Southern Copper Corp
DUS:PCU
|
US |
|
V
|
VS Industry Bhd
KLSE:VS
|
MY |
|
V
|
VitzroSys Co Ltd
KOSDAQ:054220
|
KR |
|
M
|
Micro Friend Inc
KOSDAQ:147760
|
KR |
|
T
|
Tiger Brands Ltd
JSE:TBS
|
ZA |
|
SGS SA
SIX:SGSN
|
CH |
|
Collins Foods Ltd
ASX:CKF
|
AU |
|
M
|
M&T Bank Corp
DUS:MTZ
|
US |
|
Reynolds Consumer Products Inc
NASDAQ:REYN
|
US |
|
S
|
Silicon Craft Technology PCL
SET:SICT
|
TH |
|
Sunil Healthcare Ltd
BSE:537253
|
IN |
|
V
|
Volvere PLC
LSE:VLE
|
UK |
|
Piscines Desjoyaux SA
PAR:ALPDX
|
FR |
|
Swisscom AG
F:SWJA
|
CH |
|
BeOne Medicines AG
NASDAQ:ONC
|
CH |
Dr Martens PLC
Dr Martens makes and sells boots, shoes, sandals, and some accessories under the Dr. Martens brand. Its best-known products are the leather lace-up boots with thick soles, which are bought by people who want a durable, recognizable style as well as practical footwear. The company also sells into workwear and casual fashion, but its core identity comes from that one iconic boot shape and brand image. Its main customers are everyday shoppers, fashion-focused buyers, and wholesale partners such as shoe stores and department stores. Dr Martens makes money mostly by selling footwear directly through its own stores and online channels, and by selling through third-party retailers around the world. That mix lets it reach customers in both premium retail and mass fashion channels. What makes the business different is that it is a brand-first footwear company, not a general shoe maker. It competes on design, heritage, and product durability rather than on low prices. In practice, Dr Martens sits between a fashion brand and a footwear manufacturer: it creates a distinctive product, protects the brand, and uses global retail and wholesale distribution to turn that recognition into sales.
Dr Martens makes and sells boots, shoes, sandals, and some accessories under the Dr. Martens brand. Its best-known products are the leather lace-up boots with thick soles, which are bought by people who want a durable, recognizable style as well as practical footwear. The company also sells into workwear and casual fashion, but its core identity comes from that one iconic boot shape and brand image.
Its main customers are everyday shoppers, fashion-focused buyers, and wholesale partners such as shoe stores and department stores. Dr Martens makes money mostly by selling footwear directly through its own stores and online channels, and by selling through third-party retailers around the world. That mix lets it reach customers in both premium retail and mass fashion channels.
What makes the business different is that it is a brand-first footwear company, not a general shoe maker. It competes on design, heritage, and product durability rather than on low prices. In practice, Dr Martens sits between a fashion brand and a footwear manufacturer: it creates a distinctive product, protects the brand, and uses global retail and wholesale distribution to turn that recognition into sales.
Revenue Growth: Revenue rose slightly year-on-year to GBP 327.3 million, driven by improved full-price sales and reduced markdowns.
Profit Turnaround: Operating profit swung from a loss last year to a GBP 3.4 million profit, with adjusted EBIT benefiting from higher selling prices and lower costs.
Cash & Debt: Net bank debt reduced by GBP 33 million to GBP 154 million, and leverage ratios improved, positioning the company well for the year ahead.
Strategy Execution: Management remains on track with their strategic plan, focusing on reducing discount reliance, growing new product families, expanding in key markets, and simplifying operations.
Regional Performance: Americas and APAC performed strongly, while EMEA faced challenges due to a more cautious consumer and a deliberate reduction in discounts.
Tariff Mitigation: Actions taken will offset most U.S. tariff headwinds by FY '27, with about half the impact already mitigated in the current year.
Confident Outlook: Management reiterated confidence in full-year guidance and highlighted significant long-term growth opportunities.